판헤마틴(Panhematin) 시장 보고서(2026년) : 역학, 파이프라인 분석, 시장 동향과 예측

Panhematin is a hemin-based medication primarily used to treat acute porphyrias, a group of rare metabolic disorders that affect heme production. It works by restoring heme levels, which helps suppress the buildup of porphyrin precursors that trigger symptoms.

The main forms of Panhematin are 350 mg and 313 mg. The 350 mg dose is used specifically for managing acute porphyria episodes. Its primary indication is acute porphyria, and it is administered in settings such as hospitals and pharmacies.

Tariffs have affected the panhematin market by increasing costs associated with imported hemin raw materials, sterile formulation processes, and hospital supply logistics. These impacts are significant due to low volume and high value treatment profiles. Regions dependent on cross-border pharmaceutical sourcing such as north america and europe face supply sensitivity. However, tariffs are encouraging regional production and secure supply agreements. This supports long-term availability for critical rare disease therapies.

The panhematin market research report is one of a series of new reports from The Business Research Company that provides panhematin market statistics, including panhematin industry global market size, regional shares, competitors with a panhematin market share, detailed panhematin market segments, market trends and opportunities, and any further data you may need to thrive in the panhematin industry. This panhematin market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The panhematin market size has grown rapidly in recent years. It will grow from $2.42 million in 2025 to $2.71 million in 2026 at a compound annual growth rate (CAGR) of 12.1%. The growth in the historic period can be attributed to limited treatment options for porphyria, orphan drug approvals, hospital emergency usage, specialist metabolic disorder centers, patient advocacy efforts.

The panhematin market size is expected to see rapid growth in the next few years. It will grow to $4.24 million in 2030 at a compound annual growth rate (CAGR) of 11.8%. The growth in the forecast period can be attributed to improved rare disease diagnosis, expansion of acute porphyria awareness, increased access to orphan drugs, supportive reimbursement policies, growth of specialty care centers. Major trends in the forecast period include rising use in acute porphyria management, growth of orphan drug treatments, increased focus on rare metabolic disorders, expansion of hospital based emergency therapies, improved diagnostic awareness of porphyria.

The increasing diagnosis of genetic disorders is expected to drive the growth of the Panhematin market in the coming years. Genetic disorders are medical conditions caused by abnormalities in an individual's genetic material and often require specialized treatments. The rise in diagnoses is driven by advancements in genetic testing and growing awareness, which enable early detection and timely intervention. Panhematin, used in the treatment of acute porphyrias, provides a synthetic form of heme that helps restore the body's ability to regulate porphyrin and heme production. This alleviates symptoms such as severe abdominal pain, nausea, and neurological complications that result from the accumulation of toxic porphyrins due to enzyme deficiencies in the heme biosynthesis pathway. For example, in April 2023, the New England Journal of Medicine, a US-based medical journal, reported that approximately 5,500 individuals with severe developmental disorders have now been identified with the genetic cause of their condition. Therefore, the rising diagnosis of genetic disorders is driving the Panhematin market.

The increasing prevalence of blood disorders is also expected to support the growth of the Panhematin market. Blood disorders affect the production, function, or structure of blood cells, leading to conditions such as anemia, clotting problems, or immune dysfunction. The rise in blood disorders is primarily due to genetic predispositions, lifestyle changes, environmental factors, and aging populations. Panhematin, a form of heme arginate, helps patients with blood disorders, particularly acute intermittent porphyria and related conditions, by supplying a synthesized heme molecule that bypasses defective enzymes in the heme production pathway. This reduces the toxic buildup of porphyrins and alleviates symptoms such as pain, weakness, and neurological disturbances. For instance, in May 2024, the National Health Service (NHS) England, a UK-based government-funded healthcare system, reported that approximately 17,000 people in England are living with sickle cell disease, an inherited blood disorder, with around 250 new cases diagnosed annually. Consequently, the rising incidence of blood disorders is driving the Panhematin market.

Rising healthcare expenditure is further expected to propel the growth of the Panhematin market. Healthcare expenditure refers to the financial resources allocated to medical services, including diagnostics, treatments, and therapies, by governments, private entities, and individuals. The growth in spending is driven by an aging population, prevalence of chronic diseases, advances in medical technology, and increased demand for quality healthcare services. For Panhematin, healthcare expenditure covers the cost of treating acute porphyria attacks, including the drug itself, hospitalization, and associated care, ensuring effective management of this rare genetic disorder. For example, in May 2024, the Office for National Statistics, a UK-based government agency, reported that total healthcare expenditure increased by 5.6% in nominal terms from 2022 to 2023, compared to 0.9% growth in 2022. Additionally, long-term health and social care expenditure rose by 2.8% in real terms in 2022. Therefore, rising healthcare expenditure is driving the Panhematin market.

Major companies operating in the panhematin market are Horizon Therapeutics plc.

North America was the largest region in the panhematin market in 2025. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the panhematin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the panhematin market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

The panhematin market consists of sales of intravenous (IV) formulations used to treat acute intermittent porphyria (AIP) and related heme synthesis disorders. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Panhematin Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses panhematin market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for panhematin ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The panhematin market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Type: 350mg; 313mg
• 2) By Indication: Acute Porphyria; Other Indications
• 3) By Application: Hospital; Pharmacy
• Companies Mentioned: Horizon Therapeutics plc.
• Countries: Australia; India; China; South Korea; Japan; UK; France; Germany; USA; Canada.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Panhematin Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Panhematin Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Panhematin Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Panhematin Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Artificial Intelligence & Autonomous Intelligence
  • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.4 Industry 4.0 & Intelligent Manufacturing
  • 4.1.5 Sustainability, Climate Tech & Circular Economy
• 4.2. Major Trends
  • 4.2.1 Rising Use In Acute Porphyria Management
  • 4.2.2 Growth Of Orphan Drug Treatments
  • 4.2.3 Increased Focus On Rare Metabolic Disorders
  • 4.2.4 Expansion Of Hospital Based Emergency Therapies
  • 4.2.5 Improved Diagnostic Awareness Of Porphyria

5. Panhematin Market Analysis Of End Use Industries

• 5.1 Hospitals
• 5.2 Specialty Clinics
• 5.3 Emergency Care Centers
• 5.4 Metabolic Disorder Centers
• 5.5 Hospital Pharmacies

6. Panhematin Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Panhematin Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Panhematin PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Panhematin Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Panhematin Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Panhematin Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Panhematin Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Panhematin Market Segmentation

• 9.1. Global Panhematin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 350mg, 313mg
• 9.2. Global Panhematin Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Acute Porphyria, Other Indications
• 9.3. Global Panhematin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospital, Pharmacy

10. Panhematin Market Regional And Country Analysis

• 10.1. Global Panhematin Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Panhematin Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Panhematin Market

• 11.1. Asia-Pacific Panhematin Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Panhematin Market, Segmentation By Type, Segmentation By Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Panhematin Market

• 12.1. China Panhematin Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Panhematin Market, Segmentation By Type, Segmentation By Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Panhematin Market

• 13.1. India Panhematin Market, Segmentation By Type, Segmentation By Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Panhematin Market

• 14.1. Japan Panhematin Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Panhematin Market, Segmentation By Type, Segmentation By Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Panhematin Market

• 15.1. Australia Panhematin Market, Segmentation By Type, Segmentation By Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. South Korea Panhematin Market

• 16.1. South Korea Panhematin Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 16.2. South Korea Panhematin Market, Segmentation By Type, Segmentation By Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. Western Europe Panhematin Market

• 17.1. Western Europe Panhematin Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. Western Europe Panhematin Market, Segmentation By Type, Segmentation By Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. UK Panhematin Market

• 18.1. UK Panhematin Market, Segmentation By Type, Segmentation By Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. Germany Panhematin Market

• 19.1. Germany Panhematin Market, Segmentation By Type, Segmentation By Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. France Panhematin Market

• 20.1. France Panhematin Market, Segmentation By Type, Segmentation By Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. Eastern Europe Panhematin Market

• 21.1. Eastern Europe Panhematin Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 21.2. Eastern Europe Panhematin Market, Segmentation By Type, Segmentation By Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. North America Panhematin Market

• 22.1. North America Panhematin Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 22.2. North America Panhematin Market, Segmentation By Type, Segmentation By Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. USA Panhematin Market

• 23.1. USA Panhematin Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 23.2. USA Panhematin Market, Segmentation By Type, Segmentation By Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Canada Panhematin Market

• 24.1. Canada Panhematin Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 24.2. Canada Panhematin Market, Segmentation By Type, Segmentation By Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. South America Panhematin Market

• 25.1. South America Panhematin Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 25.2. South America Panhematin Market, Segmentation By Type, Segmentation By Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Middle East Panhematin Market

• 26.1. Middle East Panhematin Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Middle East Panhematin Market, Segmentation By Type, Segmentation By Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Africa Panhematin Market

• 27.1. Africa Panhematin Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 27.2. Africa Panhematin Market, Segmentation By Type, Segmentation By Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. Panhematin Market Regulatory and Investment Landscape

29. Panhematin Market Competitive Landscape And Company Profiles

• 29.1. Panhematin Market Competitive Landscape And Market Share 2024
  • 29.1.1. Top 10 Companies (Ranked by revenue/share)
• 29.2. Panhematin Market - Company Scoring Matrix
  • 29.2.1. Market Revenues
  • 29.2.2. Product Innovation Score
  • 29.2.3. Brand Recognition
• 29.3. Panhematin Market Company Profiles
  • 29.3.1. Horizon Therapeutics plc. Overview, Products and Services, Strategy and Financial Analysis

30. Global Panhematin Market Competitive Benchmarking And Dashboard

31. Key Mergers And Acquisitions In The Panhematin Market

32. Panhematin Market High Potential Countries, Segments and Strategies

• 32.1 Panhematin Market In 2030 - Countries Offering Most New Opportunities
• 32.2 Panhematin Market In 2030 - Segments Offering Most New Opportunities
• 32.3 Panhematin Market In 2030 - Growth Strategies
  • 32.3.1 Market Trend Based Strategies
  • 32.3.2 Competitor Strategies

33. Appendix

• 33.1. Abbreviations
• 33.2. Currencies
• 33.3. Historic And Forecast Inflation Rates
• 33.4. Research Inquiries
• 33.5. The Business Research Company
• 33.6. Copyright And Disclaimer